價格 | 詢價 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-08-02 |
中文名稱:Recombinant Human p16-INK4a | 英文名稱:Recombinant Human p16-INK4a |
有效期: 一年 | 產(chǎn)品類別: 重組蛋白 其他重組蛋白 |
產(chǎn)品編號 | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價格 |
P7181-1mg | Recombinant Human p16-INK4a | 1mg | 詢價 |
Species | Gene ID | Accession | Source | Length | MW | Tag |
Human | 1029 | P42771 | E. coli | 156aa | 16.5kDa | - |
About this Antibody | |
Name | Recombinant Human p16-INK4a (Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A, Isoform 1; rHup16-INK4a);重組人細(xì)胞周期蛋白依賴激酶抑制劑2A,同工酶1 |
Synonyms | ARF; CDK4I; CDKN2A; INK4a; MLM; p14ARF; p16; p19ARF; ARF; CDK4 inhibitor p16-INK4; CDK4IP14ARF; CDKN2; cell cycle negative regulator beta; CMM2P16-INK4A; Cyclin-dependent kinase 4 inhibitor A; cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); INK4; INK4A; INK4a; MLMP16INK4; MTS-1; MTS1P14; Multiple tumor suppressor 1; p14; p14ARF; P16; p16; p16-INK4; p16INK4a; p16INK4A; P16INK4A; p16-INK4a; p19; P19; p19ARF; p19Arf; P19ARF; TP16 |
Purity | >96% by SDS-PAGE and HPLC analyses. |
Biological Activity | Data Not Available. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH7.4. |
Endotoxin | Less than 1EU/μg of rHuP16-INK4a as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions. |
Category | Others |
Background | Cyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins. p16-INK4A is the member of p16 family and is encoded by CDKN2A gene in humans. It has three isoforms, which are wildly expressed but not detected in brain or skeletal muscle, except that isoform 3 is pancreas-specific. Defects in p16INK4A are a cause of Li-Fraumeni syndrome (LFS) and melanoma-astrocytoma syndrome (MASTS). |
Amino Acid Sequence | MEPAAGSSME PSADWLATAA ARGRVEEVRA LLEAGALPNA PNSYGRRPIQ VMMMGSARVA ELLLLHGAEP NCADPATLTR PVHDAAREGF LDTLVVLHRA GARLDVRDAW GRLPVDLAEE LGHRDVARYL RAAAGGTRGS NHARIDAAEG PSDIPD |
包裝清單:
產(chǎn)品編號 | 產(chǎn)品名稱 | 包裝 |
P7181-10μg | Recombinant Human p16-INK4a | 10μg |
P7181-50μg | Recombinant Human p16-INK4a | 50μg |
P7181-100μg | Recombinant Human p16-INK4a | 100μg |
P7181-1mg | Recombinant Human p16-INK4a | 1mg |
- | 說明書 | 1份 |
保存條件:
???????-20℃或更低溫度保存,至少一年有效。由于蛋白的每次凍融均會引起部分失活,所以首次配制成相應(yīng)濃度的儲存液后(請根據(jù)產(chǎn)品簡介中Reconstitution一欄的信息配制儲存液),須分裝后-20℃或更低溫度凍存,以避免反復(fù)凍融。
注意事項:
???????由于有些塑料管壁對某些蛋白有較強(qiáng)的吸附作用,溶液中的蛋白很容易粘附在管壁上,并且粘附后的蛋白很難與管壁分離。而載體蛋白(Carrier protein,如0.1% BSA等)的主要作用是預(yù)先封閉塑料管壁上的蛋白結(jié)合位點(diǎn),使細(xì)胞因子或重組蛋白不會粘附于管壁。所以一定要使用產(chǎn)品簡介中Reconstitution一欄的信息配制儲存液。
???????本產(chǎn)品僅限于專業(yè)人員的科學(xué)研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內(nèi)。
???????為了您的安全和健康,請穿實(shí)驗服并戴一次性手套操作。
成立日期 | 2007-07-19 (19年) | 注冊資本 | 1000.000000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學(xué),生物活性小分子 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP4年
|
廣州瓏瑩生物科技有限公司
|
2025-08-08 | |
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-08-08 | |
¥1098 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2025-08-08 |